National Bank of Canada FI Raises Stock Holdings in Axon Enterprise, Inc $AXON

National Bank of Canada FI increased its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 19.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 82,534 shares of the biotechnology company’s stock after purchasing an additional 13,638 shares during the quarter. National Bank of Canada FI owned 0.11% of Axon Enterprise worth $68,326,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in AXON. Hemington Wealth Management lifted its position in Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 17 shares in the last quarter. Whipplewood Advisors LLC increased its position in Axon Enterprise by 192.9% in the second quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after buying an additional 27 shares in the last quarter. Darwin Wealth Management LLC bought a new position in shares of Axon Enterprise in the second quarter worth about $37,000. NewSquare Capital LLC lifted its position in shares of Axon Enterprise by 96.2% during the 2nd quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock valued at $42,000 after buying an additional 25 shares in the last quarter. Finally, Washington Trust Advisors Inc. lifted its position in shares of Axon Enterprise by 44.7% during the 2nd quarter. Washington Trust Advisors Inc. now owns 55 shares of the biotechnology company’s stock valued at $46,000 after buying an additional 17 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 2.9%

AXON opened at $564.28 on Monday. The stock has a fifty day moving average price of $623.94 and a 200-day moving average price of $713.90. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57. Axon Enterprise, Inc has a 12 month low of $469.24 and a 12 month high of $885.91. The firm has a market cap of $44.53 billion, a price-to-earnings ratio of 178.57, a PEG ratio of 129.60 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.46). Axon Enterprise had a net margin of 10.05% and a return on equity of 4.29%. The company had revenue of $710.64 million during the quarter, compared to analysts’ expectations of $704.83 million. During the same period in the previous year, the business earned $1.45 earnings per share. The business’s revenue for the quarter was up 30.6% compared to the same quarter last year. As a group, equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Activity at Axon Enterprise

In other news, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $552.60, for a total value of $11,052,000.00. Following the completion of the transaction, the president owned 249,502 shares in the company, valued at approximately $137,874,805.20. This trade represents a 7.42% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $551.92, for a total value of $5,519,200.00. Following the completion of the sale, the chief executive officer directly owned 3,110,997 shares of the company’s stock, valued at approximately $1,717,021,464.24. This trade represents a 0.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 64,406 shares of company stock valued at $38,521,038. 5.70% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on AXON shares. Needham & Company LLC reissued a “buy” rating and issued a $870.00 price objective on shares of Axon Enterprise in a research note on Wednesday, September 24th. Piper Sandler cut their price target on Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. The Goldman Sachs Group decreased their price target on Axon Enterprise from $940.00 to $800.00 and set a “buy” rating on the stock in a report on Wednesday, November 5th. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. Finally, Wall Street Zen cut Axon Enterprise from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $815.00.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.